A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Zavation Medical Products Launches Z-Span Expandable Anterior And Lateral Lumbar Plates

Zavation Medical Products has announced the launch of both the Expandable Anterior Lumbar Plate and the Expandable Lateral Lumbar Plate, plates designed for use in the lumbar spine as supplemental fixation devices.

These expandable plates are the latest additions to Zavation’s portfolio. The Expandable Anterior Lumbar Plate is a low-profile plate design that provides a stable construct with the ability to expand and lock at the required length. This plate also includes a ledge feature that provides guidance to properly position and expand the plate on the vertebral body. The new Z-Span plates outperformed the predicates in regard to standard ASTM mechanical testing.

Dr. Eric Graham, Spine Surgeon at Bienville Orthopaedic Specialists, stated, “This design eliminates the frustration of trying several plates in an effort to best match each patient’s anatomy. This equates to a more efficient surgery.”

INDICATIONS FOR USE
The Zavation Z-Span Plate System is intended for use via the lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of the lumbar spine (L1-L5) or via the anterior approach below the bifurcation of the great vessels in the treatment of the lumbar and lumbosacral spine (L1-S1).

The Z-Span Plate System is intended to provide immobilization and stabilization as an adjunct to fusion in skeletally mature patients.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy